13-1720
Hydrochloric acid
0.2 M
Synonym(s):
Hydrogen chloride solution
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
HCl
CAS Number:
Molecular Weight:
36.46
PubChem Substance ID:
UNSPSC Code:
12352301
MDL number:
Concentration:
0.2 M, 1/5 N
Form:
liquid
Product Name
Hydrochloric acid solution, 0.2 M
vapor pressure
190 mmHg ( 25 °C)
form
liquid
availability
available only in Japan
concentration
0.2 M, 1/5 N
bp
100 °C (lit.)
density
1 g/cm3 at 20 °C
SMILES string
Cl
InChI
1S/ClH/h1H
InChI key
VEXZGXHMUGYJMC-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under Hydrochloric acid solution
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Storage Class
12 - Non Combustible Liquids
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Charlotte Strandgren et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 29(8), 3193-3205 (2015-04-17)
Hutchinson-Gilford progeria syndrome (HGPS) is a rare premature aging disorder that is most commonly caused by a de novo point mutation in exon 11 of the LMNA gene, c.1824C>T, which results in an increased production of a truncated form of
B Kalyanasundar et al.
Journal of neurophysiology, 114(1), 585-607 (2015-05-15)
Obesity is a worldwide health problem that has reached epidemic proportions. To ameliorate this problem, one approach is the use of appetite suppressants. These compounds are frequently amphetamine congeners such as diethylpropion (DEP), phentermine (PHEN), and bupropion (BUP), whose effects
Brian W Simons et al.
The Journal of pathology, 235(3), 478-489 (2014-10-29)
Inflammation is associated with several diseases of the prostate including benign enlargement and cancer, but a causal relationship has not been established. Our objective was to characterize the prostate inflammatory microenvironment after infection with a human prostate-derived bacterial strain and